Survodutide: The GLP-1/Glucagon Dual Agonist Reshaping Metabolic Treatment
Review of survodutide, a dual GLP-1/glucagon agonist, covers its unique mechanism, clinical trial results, and potential to reshape cardiometabolic disease treatment.
Quick Facts
What This Study Found
Review of survodutide, a dual GLP-1/glucagon agonist, covers its unique mechanism, clinical trial results, and potential to reshape cardiometabolic disease treatment.
Key Numbers
How They Did This
In publication.
Why This Research Matters
Relevant to peptide therapeutics.
The Bigger Picture
Advances peptide evidence.
What This Study Doesn't Tell Us
In publication.
Questions This Raises
- ?Long-term implications?
- ?Evidence comparison?
- ?Next steps?
Trust & Context
- Key Stat:
- Key finding Review of survodutide, a dual GLP-1/glucagon agonist, covers its unique mechanism, clinical trial re
- Evidence Grade:
- Based on design.
- Study Age:
- Published in 2025.
- Original Title:
- Survodutide: A Dual GLP-1/Glucagon Agonist Reshaping Cardiometabolic Care.
- Published In:
- Cardiology in review (2025)
- Database ID:
- RPEP-09992
Evidence Hierarchy
Frequently Asked Questions
What does this mean?
Review of survodutide, a dual GLP-1/glucagon agonist, covers its unique mechanism, clinical trial results, and potential to reshape cardiometabolic disease treatment.
How reliable?
Consult publication.
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-09992APA
Arun, Amogh Jyothi; Darji, Bhavika; Baig, Madiha; Frishman, William H; Aronow, Wilbert S. (2025). Survodutide: A Dual GLP-1/Glucagon Agonist Reshaping Cardiometabolic Care.. Cardiology in review. https://doi.org/10.1097/CRD.0000000000001062
MLA
Arun, Amogh Jyothi, et al. "Survodutide: A Dual GLP-1/Glucagon Agonist Reshaping Cardiometabolic Care.." Cardiology in review, 2025. https://doi.org/10.1097/CRD.0000000000001062
RethinkPeptides
RethinkPeptides Research Database. "Survodutide: A Dual GLP-1/Glucagon Agonist Reshaping Cardiom..." RPEP-09992. Retrieved from https://rethinkpeptides.com/research/arun-2025-survodutide-a-dual-glp1glucagon
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.